These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22118753)

  • 21. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.
    Liu CJ; Chen PJ; Jeng YM; Huang WL; Yang WS; Lai MY; Kao JH; Chen DS
    J Hepatol; 2005 Aug; 43(2):235-42. PubMed ID: 15964656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
    Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
    Cua IH; Hui JM; Kench JG; George J
    Hepatology; 2008 Sep; 48(3):723-31. PubMed ID: 18688878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
    Giannini E; Botta F; Borro P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Mamone M; Testa R
    Am J Gastroenterol; 2003 Nov; 98(11):2516-20. PubMed ID: 14638357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
    Poustchi H; Negro F; Hui J; Cua IH; Brandt LR; Kench JG; George J
    J Hepatol; 2008 Jan; 48(1):28-34. PubMed ID: 17977612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum adiponectin in chronic hepatitis C and B.
    Siagris D; Vafiadis G; Michalaki M; Lekkou A; Starakis I; Makri M; Margaritis V; Christofidou M; Tsamandas AC; Labropoulou-Karatza C
    J Viral Hepat; 2007 Aug; 14(8):577-83. PubMed ID: 17650292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection.
    Corbetta S; Redaelli A; Pozzi M; Bovo G; Ratti L; Redaelli E; Pellegrini C; Beck-Peccoz P; Spada A
    Eur J Clin Invest; 2011 Aug; 41(8):898-905. PubMed ID: 21539538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.
    Wong VW; Wong GL; Yu J; Choi PC; Chan AW; Chan HY; Chu ES; Cheng AS; Chim AM; Chan FK; Sung JJ; Chan HL
    Am J Gastroenterol; 2010 Jan; 105(1):132-8. PubMed ID: 19809411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum lipid pattern in chronic hepatitis C: histological and virological correlations.
    Siagris D; Christofidou M; Theocharis GJ; Pagoni N; Papadimitriou C; Lekkou A; Thomopoulos K; Starakis I; Tsamandas AC; Labropoulou-Karatza C
    J Viral Hepat; 2006 Jan; 13(1):56-61. PubMed ID: 16364083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of histological activity and fibrosis in chronic Hepatitis C infection: a study from North India.
    Singh S; Gupta R; Malhotra V; Sarin SK
    Indian J Pathol Microbiol; 2010; 53(2):238-43. PubMed ID: 20551524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
    J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.
    Arenas JI; Gallegos-Orozco JF; Laskus T; Wilkinson J; Khatib A; Fasola C; Adair D; Radkowski M; Kibler KV; Nowicki M; Douglas D; Williams J; Netto G; Mulligan D; Klintmalm G; Rakela J; Vargas HE
    J Infect Dis; 2004 Jun; 189(11):2037-46. PubMed ID: 15143471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
    Tsochatzis E; Papatheodoridis GV; Koliaraki V; Hadziyannis E; Kafiri G; Manesis EK; Mamalaki A; Archimandritis AJ
    J Viral Hepat; 2010 Nov; 17(11):800-6. PubMed ID: 20002304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.
    Vidali M; Tripodi MF; Ivaldi A; Zampino R; Occhino G; Restivo L; Sutti S; Marrone A; Ruggiero G; Albano E; Adinolfi LE
    J Hepatol; 2008 Mar; 48(3):399-406. PubMed ID: 18164507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.